Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06973317

Self-Powered Photodetectors for Smarter Healthcare

The goal of this observational study is to evaluate the performance of a novel, non-invasive sensor device based on zirconium oxide photodetector designed to monitor key physiological parameters: blood glucose levels, heart rate, and blood oxygen saturation. The study focuses on adult hospital patients aged 18 to 75, of all sexes, who are undergoing routine monitoring and treatment unrelated to the investigational device.

The main questions this study aims to answer are:

To what extent do the signals obtained from the newly developed device correlate with standard hospital-based methods for measuring blood glucose, heart rate, and blood oxygen saturation?

Is the device feasible, safe, and accurate for use in a real-world clinical setting?

How stable and reproducible are the sensor signals across a demographically diverse patient population?

Can advanced data analysis methods, such as machine learning techniques, be used effectively to interpret the device's output and provide accurate estimates of glucose concentration?

What is the user perception of comfort, safety, and practicality when the device is used in a routine hospital environment?

This study will not assign any interventions to participants; it is purely observational. The novel device is non-invasive, and its use will not interfere with standard clinical care. Measurements will be taken passively or concurrently with routine care procedures.

Participants will:

Continue to receive standard clinical care, including conventional monitoring of glucose, heart rate, and oxygen saturation.

Undergo additional measurements using the investigational device, which will be placed non-invasively on the skin (finger).

Answer a short usability questionnaire assessing their experience with the device, including any discomfort, perceived safety, or ease of use.

Data obtained from the device will be compared with routine clinical data from standard hospital devices (e.g., glucometers, pulse oximeters) to evaluate accuracy and reliability. No pharmacological, radiological, or invasive procedures will be involved.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Endocrinology, Diabetology and Internal Medicine at the T. Marciniak Lower Silesian Specialist Hospital in Wrocław

Wroclaw, Lower Silesian Voivodeship, 54-049, Poland

Location contact

Katarzyna Gwóźdź

PRINCIPAL_INVESTIGATOR

Tomasz Tomkalski

CONTACT

[email protected]

+48 71 306 47 85

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18-75 years
  • Able to provide informed consent

Exclusion criteria

  • Skin diseases or injuries on the fingers (e.g., psoriasis, open wounds, burns)
  • Tattoos on the fingers
  • Severe peripheral circulation disorders
  • Pregnancy
  • Presence of active implantable medical devices (e.g., pacemakers)

Treatment and study plan

Primary outcomes

  1. Evaluation of a Non-Invasive Device for Measuring Blood Glucose, Heart Rate, and Oxygen Saturation

    Time frame: 8 months

    To evaluate the correlation between the signals obtained from the newly developed non-invasive device and standard hospital-based methods for measuring blood glucose levels, heart rate, and blood oxygen saturation. The primary aim is to assess the feasibility, signal stability, and potential accuracy of the investigational device in a clinical setting.

Secondary outcomes

  1. User-friendliness and Practical Usability of the Device in Routine Hospital Procedures

    Time frame: 8 months

    Usability of the device will be assessed using a standardized questionnaire (e.g., System Usability Scale, SUS) completed by clinical staff after performing routine procedures with the device. Additional measures will include the average time (in minutes) required to complete the procedure and the number of use-related errors observed per procedure, recorded by a trained observer.

  2. Variability of Device Readings Across a Demographically Diverse Adult Population

    Time frame: 8 months

    The device's output readings-heart rate (beats per minute), oxygen saturation (%SpO₂), and glucose levels (mg/dL)-will be collected from adult participants aged 18-75, balanced by sex. For each physiological parameter, variability will be assessed using standard deviation and coefficient of variation across repeated measurements. Device readings will be compared to reference standard measurements performed during the patients' routine hospital stay (e.g., laboratory tests) to evaluate consistency.

  3. Applying Machine Learning to Interpret Non-Invasive PPG Signals for Glucose Estimation

    Time frame: 12 months

    To apply and evaluate machine learning techniques for the interpretation of non-invasive PPG signals, in order to estimate glucose levels and benchmark the performance of the sensor platform

Sponsors and collaborators

Lead sponsor

Wrocław University of Science and Technology

Other

Collaborators

  • T. Marciniak Lower Silesian Specialist Hospital in Wrocław

Registry information

Acronym: SPARC

Important dates

Study start
2027
Primary completion
2028
Study completion
2028
First posted
May 15, 2025
Registry last updated
Jul 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.